Location History:
- Germering, DE (2000 - 2014)
- München, DE (2006 - 2014)
Company Filing History:
Years Active: 2000-2014
Title: Robert Huber: Pioneering Innovations in Biotechnology
Introduction:
In the world of biotechnology, Robert Huber has established himself as a visionary inventor, dedicated researcher, and collaborator extraordinaire. Based in Germering, Germany, Huber has made significant contributions to the field, with numerous patents to his name. This article explores his latest patents, career highlights, and notable collaborations that have shaped his impressive journey.
Latest Patents:
Over the course of his career, Robert Huber has obtained a remarkable total of 14 patents. The following are highlights of his most recent patent inventions:
1. Substance binding human IgG Fc receptor IIb (FcγRIIb):
This invention revolves around the development of novel immunogens that carry conformationally discriminating epitopes (CDEs). Huber's immunization methods produce antibodies that specifically recognize proteins closely related to FcγRIIb, such as FcγRIIa. These antibodies hold immense potential for diagnostics and pharmaceutical applications, as well as the generation of crystal structure data for artificial molecule modeling.
2. Recombinant soluble FC receptors:
Huber's patented invention relates to recombinant soluble Fc receptors characterized by their absence of transmembrane domains, signal peptides, and glycosylation. Easily obtained through the expression of relevant nucleic acids in prokaryotic host cells, these Fc receptors yield highly pure and homogeneous products. They find applications in diagnostics, pharmaceuticals, crystal structure data generation, and even antibody separation and enrichment using solid materials.
Career Highlights:
Robert Huber's career showcases his dedication to advancing biotechnological innovations. Throughout the years, he has held significant positions in renowned institutions, demonstrating his expertise and commitment to the field. Notable career highlights include:
1. Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.:
During his tenure at the Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., Huber contributed extensively to the institution's prestigious reputation as a leading research organization. Working alongside talented scientists, he made breakthroughs in biotechnology and laid the foundation for his groundbreaking patents.
2. Boehringer Mannheim GmbH:
Huber's association with Boehringer Mannheim GmbH further solidified his position as a key innovator in biotechnology. His contributions to the company's research and development efforts propelled advancements in drug discovery and diagnostics, making a tangible impact on the healthcare industry.
Collaborations:
Robert Huber's collaborations have been instrumental in furthering his inventions and expanding the horizons of biotechnology. Notable collaborators include:
1. Wolfram Bode:
Working alongside Wolfram Bode, an esteemed molecular biologist, Huber leveraged their combined expertise to unlock new possibilities in immunology research. Their collaborative efforts contributed to the successful development of innovative immunogens and antibodies, shaping the future of diagnostics and therapeutics.
2. Uwe Jacob:
Collaborating with Uwe Jacob, a renowned biochemist, Huber pioneered the innovative production of recombinant soluble Fc receptors. Their partnership resulted in significant advancements in protein engineering and opened up new avenues for diagnostic applications, crystal structure studies, and antibody separation techniques.
Conclusion:
Robert Huber, with his brilliant mind and unwavering dedication, has made a lasting impact on the field of biotechnology. His fascinating inventions, such as the substance binding human IgG Fc receptor IIb and recombinant soluble Fc receptors, have paved the way for novel diagnostic and therapeutic approaches. Through collaborations with like-minded individuals and renowned organizations like Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. and Boehringer Mannheim GmbH, Huber's work continues to shape the future of biotechnology and inspire the next generation of innovators in this field.

